Vegf or EphA2 antisense polyamide-nucleic acids; vascular localization and suppression of retinal neovascularization

Molecular Therapy

Volumn 15, Issue 11, 2007, Pages 1924-1930

  Shen, Jikui ^a   Xie, Bing ^a   Hatara, Christina M ^a   Hackett, Sean F ^a   Campochiaro, Peter A ^a  

^a JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CELL RECEPTOR; COMPLEMENTARY DNA; COMPLEMENTARY RNA; CYCLIC AMP RESPONSIVE ELEMENT BINDING PROTEIN; DEOXYRIBONUCLEOPROTEIN; EPHRIN A2; FLUORESCEIN ISOTHIOCYANATE; NUCLEIC ACID; POLYAMIDE; VASCULOTROPIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BINDING AFFINITY; CELL TRANSPORT; CHIMERA; CHOROID VASCULARIZATION; CONTROLLED STUDY; ENDOTHELIUM CELL; FEMALE; GENE EXPRESSION; GENE LOCATION; GENE TARGETING; HUMAN; MOUSE; NONHUMAN; PROTEIN MODIFICATION; RETINA BLOOD VESSEL; RETINA ISCHEMIA; RETINA NEOVASCULARIZATION; SIGNAL TRANSDUCTION; STAINING;

EID: 35548935070     PISSN: 15250016     EISSN: 15250024     Source Type: Journal    
DOI: 10.1038/sj.mt.6300276     Document Type: Article

References (26)

1. Nielsen, PE, Egholm, M, Berg, RH and Buchardt, O (1991). Sequence-selective recognition of DNA by strand displacement with a thymine-substituted polyamide. Science 254: 1497-1500.
2. Egholm, M, Buchardt, O, Christensen, L, Behrens, C, Freler, SM, Driver, DA et al. (1993). PNA hybridizes to complementary oligonucleotides obeying the Watson-Crick hydrogen-bonding rules. Nature 365: 566-568.
3. van der Laan, AC, Stromberg, R, van Boom, JH and Kuyi-Yeheskiely, E (1996). An approach towards the synthesis of oligomers containing a N 2-hydroxyethyl-aminomethylphosphonate backbone: A novel PNA analogue. Tetrahedron Lett 43: 7857-7860.
4. Efimov, VA, Choob, MV, Buryakova, AA, Kalinkina, AL and Chakhmakhcheva, OG (1998). Synthesis and evaluation of some properties of chimeric oligomers containing PNA and phosphono-PNA residues. Nucleic Acids Res 26: 566-575.
5. Efimov, V, Choob, M, Buryakova, A, Phelan, D and Chakhmakhcheva, OG (2001). PNA-related oligonucleotide mimics and their evaluation for nucleic acid hybridization studies and analysis. Nucleosides Nucleotides Nucleic Acids 20: 419-428.
6. Shen, J, Samul, R, Silva, RL, Akiyama, H, Liu, H, Saishin, Y et al. (2005). Suppression of ocular neovascularization with siRNA targeting VEGF receptor 1. Gene Ther 13: 225-234.
7. Shen, J, Yang, X, Xiao, WH, Hackett, SF, Sato, Y and Campochiaro, PA (2006). Vasohibin is up-regulated by VEGF in the retina and suppresses VEGF receptor 2 and retinal neovascularization. FASEB J 20: 723-725.
8. Wu, Z, Rogers, B, Kachi, S, Hackett, SF, Sick A and Campochiaro, PA (2006). Reduction of p66Shc suppresses oxidative damage in retinal pigmented epithelial cells and retina. J Cell Physiol 209: 996-1005.
9. Reich, SJ, Fosnot, I, Kuroki, A, Tang, W, Yang, X, Maguire, AM et al. (2003). Small interfering RNA (siRNA) targeting VEGF effectively inhibits ocular neovascularization in a mouse model. Mol Vis 9 210-216.
10. Drescher, U, Kremoser, C, Handwerker, C, Löschinger, J, Noda, M and Bonhoeffer, F (1995). In vitro guidance of retinal ganglion cell axons by RAGS, a 25 kDa tectal protein related to ligands for Eph receptor tyrosine kinases. Cell 82: 359-370.
11. Drescher, U, Bonhoeffer, F and Müller, BK (1997). The Eph family in retinal axon guidance. Curr Opin Neurobiol 7: 75-80.
12. McBride, JL and Ruiz, JC (1998). Ephrin-A1 is expressed at sites of vascular development in the mouse. Mech Dev 77: 201-204.
13. Adams, RH, Wilkinson, GA, Weiss, C, Diella, F, Gale, NW, Deutsch, U et al. (1999). Roles of ephrinB ligiands and EphB receptors in cardiovascular development: Demarcation of arterial/venous domains, vascular morphogenesis, and spouting angiogenesis. Genes Dev 13 295-306.
14. Pandey, A, Shao, H, Marks, RM, Polverini, PJ and Dixit, VM (1995). Role of B61, the ligand for the Eck receptor tyrosine kinase, in TNF-alpha-induced angiogenesis. Science 268: 567-569.
15. Ogawa, K, Pasqualini, R, Lindberg, RA, Kain, R, Freeman, AL and Pasquale, EB (2000). The ephrin-A1 ligand and its receptor, EphA2, are expressed during tumor neovascularization. Oncogene 19: 6043-6052.
16. Chen, J, Hicks, D, Brantley-Sieders, D, Cheng, N, McCollum, GW, Qi-Werdich, X et al. (2006). Inhibition of retinal neovascularization by soluble EphA2 receptor. Exp Eye Res 82 664-673.
17. Ozaki, H, Hayashi, H, Vinores, SA, Moromizato, Y, Campochiaro, PA and Oshima, K (1997). Intravitreal sustained release of VEGF causes retinal neovascularization in rabbits and breakdown of the blood-retinal barrier in rabbits and primates. Exp Eye Res 64: 505-517.
18. Okamoto, N, Tobe, T, Hackett, SF, Ozaki, H, Vinores, MA, LaRochelle, W et al. (1997). Transgenic mice with increased expression of vascular endothelial growth factor in the retina: A new model of intraretinal and subretinal neovascularization. Am J Pathol 151 281-291.
19. Ozaki, H, Seo, MS, Ozaki, K, Yamada, H, Yamada, E, Okamoto, N et al. (2000). Blockade of vascular endothelial cell growth factor receptor signaling is sufficient to completely prevent retinal neovascularization. Am J Pathol 156: 679-707.
20. Oh, H, Takagi, H, Otani, A, Koyama, S, Kemmonchi, S, Uemura, A et al. (2002). Selective induction of neuropllin- 1 by vascular endothelial growth factor (VEGF): A mechanism contributing to VEGF-induced angiogenesis. Proc Natl Acad Sci USA 99: 383-388.
21. McLeod, DS, Taomoto, M, Cao, J, Zhu, Z, Witte, L and Lutty, GA (2002). Localization of VEGF receptor-2 (KDR/Flk- 1) and effects of blocking jt in oxygen-induced retinopathy. Invest Ophthalmol Vis Sci 43: 474-482.
22. Shen, J, Samul, R, Zimmer, J, Liu, H, Liang, X, Hackett, SF et al. (2004). Deficiency of neuropilin 2 suppresses VEGF-induced retinal neovascularization. Mol Med 10: 12-18.
23. Oshima, Y, Oshima, S, Nambu, H, Kachi, S, Takahashi, K, Umeda, N et al. (2005). Different effects of angiopoietin 2 in different vascular beds in the eye; new vessels are most sensitive. FASEB J 19: 963-965.
24. Nambu, H, Nambu, R, Oshima, Y, Hackett, SF, Okoye, G, Wiegand, S, et al. (2004). Angiopoietin 1 inhibits-ocular neovascularization and breakdown of the blood-retinal barrier. Gene Ther 11: 865-873.
25. Nambu, H, Umeda, N, Kachi, S, Oshima, Y, Akiyama, H, Nambu, R et al. (2005). Angiopoietin 1 prevents retinal detachment in an aggressive model of proliferative retinopathy, but has no effect on established neovascularization. J Cell Physiol 204: 227-235.
26. Smith, LE, Wesolowski, E, McLellan, A, Kostyk, SK, D'Amato, R, Sullivan, R et al. (1994). Oxygen-induced retinopathy in the mouse. Invest Ophthalmol Vis Sci 35: 101-111.